DBV Technologies S.A

(NASDAQ:DBVT)

Latest On DBV Technologies S.A (DBVT):

Date/Time Type Description Signal Details
2023-05-04 21:04 ESTNewsDBV Technologies GAAP EPS of -$0.22, revenue of $2.2MN/A
2023-04-07 00:17 ESTNewsDBV Technologies files for $250M mixed shelf offeringN/A
2023-03-04 07:15 ESTNewsDBV Technologies S.A. (DBVT) Q4 2022 Earnings Call TranscriptN/A
2023-03-03 02:40 ESTNewsDBV Technologies GAAP EPS of -$1.24, revenue of $4.8MN/A
2022-12-23 19:26 ESTNewsDBV stock soars 30% as FDA lifts partial hold on phase 3 trial of peanut allergy patchN/A
2022-12-19 13:08 ESTNewsDBV Technologies: Downgrade And Tax Loss Selling Create A Buying OpportunityN/A
2022-12-16 16:06 ESTNewsDBV Tech cut to Sell at Goldman on uncertainty to peanut allergy candidateN/A
2022-11-06 21:37 ESTNewsDBV Technologies S.A. (DBVT) Q3 2022 Earnings Call TranscriptN/A
2022-11-03 21:24 ESTNewsDBV Technologies GAAP EPS of -$0.18, revenue of $2.07MN/A
2022-09-21 20:09 ESTNewsFDA puts partial clinical hold on a DBT Technologies peanut allergy patch phase 3 trialN/A
2022-08-01 20:44 ESTNewsDBV Technologies GAAP EPS of -$0.35 misses by $0.03, revenue of $1.53M beats by $0.29MN/A
2022-07-07 23:39 ESTNewsDBV Technologies: Good Data, Plenty Of Cash And Regulatory UncertaintyN/A
2022-06-10 09:08 ESTNewsDBV Technologies plans to raise $194M via equity financingN/A
2022-06-10 09:08 ESTNewsDBV Technologies stock extends rally to a second day; co announces $194M financingN/A
2022-06-09 05:30 ESTNewsDBV Technologies stock dips amid plans to raise $194M via equity financingN/A
2022-06-07 22:57 ESTNewsDBV Technologies' phase 3 trial for peanut allergy treatment in toddlers meets main goalN/A
2022-05-03 07:47 ESTNewsDBV Technologies GAAP EPS of -$0.30 beats by $0.10, revenue of $2.55M beats by $1.27MN/A
2022-05-03 07:47 ESTNewsDBV Technologies S.A. (DBVT) CEO Daniel Tassé on Q1 2022 Results - Earnings Call TranscriptN/A
2022-03-04 17:04 ESTNewsDBV Technologies stock slumps 21% amid FY revenue decline, plans on Peanut patchN/A
2022-03-03 23:34 ESTNewsDBV Technologies GAAP EPS of -$1.78 beats by $0.28, revenue of $5.70M beats by $0.83MN/A
2022-03-03 23:33 ESTNewsDBV Technologies S.A. (DBVT) CEO Daniel Tassé on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-03 06:02 ESTNewsDBV Technologies FY 2021 Earnings PreviewN/A
2021-12-23 06:11 ESTNewsDBV recovers some of yesterday's losses on peanut allergy trial; shares up 13%N/A
2021-12-21 14:43 ESTNewsDBV Technologies falls after updates on Viaskin Peanut patchN/A
2021-11-03 05:58 ESTNewsWarning: DBVT is at high risk of performing badlyN/A
2021-10-29 12:11 ESTNewsViaskin peanut allergy therapy fallout continues as DBV down another 16% todayN/A
2021-10-27 11:06 ESTNewsDBV Technologies EPS beats by $0.05N/A
2021-10-27 11:06 ESTNewsDBV falls 25% as FDA seeks to review more data for Viaskin Peanut allergy therapyN/A
2021-10-16 02:19 ESTNewsDBV Technologies up 11% on unusually high volumeN/A
2021-08-03 05:38 ESTNewsDBV Technologies EPS beats by $0.01N/A
2021-08-03 05:38 ESTNewsDBV Technologies S.A. (DBVT) CEO Daniel Tassé on Q2 2021 Results - Earnings Call TranscriptN/A
2021-03-19 00:41 ESTAnalyst RatingThe Analyst Target Price has increased from $9.37 to $9.43.Buy
2021-03-17 23:35 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.38 to $9.37.Neutral
2021-03-17 15:27 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.41 to $9.38.Neutral
2021-03-16 23:58 ESTFinancialsCompany financials have been released.Neutral
2021-03-16 23:58 ESTAnalyst RatingThe Analyst Target Price has increased from $9.31 to $9.41.Buy
2021-03-13 22:10 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.33 to $9.31.Neutral
2021-03-12 22:37 ESTAnalyst RatingThe Analyst Target Price has increased from $9.18 to $9.33.Buy
2021-03-12 18:20 ESTNewsDBV Technologies S.A. (DBVT) CEO Daniel Tassé on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-11 22:42 ESTAnalyst RatingThe Analyst Target Price has increased from $9.16 to $9.18.Buy
2021-03-11 21:04 ESTNewsDBV Technologies EPS beats by $0.75, misses on revenueN/A
2021-03-11 02:21 ESTAnalyst RatingThe Analyst Target Price has increased from $9.13 to $9.16.Buy
2021-03-09 22:34 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.18 to $9.13.Neutral
2021-03-09 10:02 ESTAnalyst RatingThe Analyst Target Price has increased from $9.17 to $9.18.Buy
2021-03-07 10:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.21 to $9.17.Neutral
2021-03-05 22:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.28 to $9.21.Neutral
2021-03-05 13:45 ESTAnalyst RatingThe Analyst Target Price has increased from $9.22 to $9.28.Buy
2021-03-04 02:26 ESTAnalyst RatingThe Analyst Target Price has increased from $9.19 to $9.22.Buy
2021-03-02 22:29 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.22 to $9.19.Neutral
2021-03-01 22:15 ESTAnalyst RatingThe Analyst Target Price has increased from $9.21 to $9.22.Buy

About DBV Technologies S.A (DBVT):

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA) and milk-induced eosinophilic esophagitis; Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was founded in 2002 and is headquartered in Montrouge, France.

DBVT Quotes by TradingView

See Advanced Chart

General

  • Name DBV Technologies S.A
  • Symbol DBVT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Fiscal Year EndDecember
  • IPO Date2014-10-22
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.dbv-technologies.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.29
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Operating Margin -1194%
  • Return on Assets -30%
  • Return on Equity -77%
  • Revenue 11.28 million
  • Earnings Per Share -$3.27
  • Revenue Per Share $0.1
  • Gross Profit 11.28 million
  • Quarterly Earnings Growth 32.6%
View More

Highlights

  • Market Capitalization 606.86 million
  • Analyst Target Price $9.43
  • Book Value Per Share $1.88
View More

Share Statistics

  • Shares Outstanding 109.78 million
  • Shares Float 62.26 million
  • % Held by Insiders <1%
  • % Held by Institutions 33.81%
  • Shares Short 1.39 million
  • Shares Short Prior Month 1.45 million
  • Short Ratio 4.89
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 2.21
  • 52 Week High $7
  • 52 Week Low $1.35
  • 50 Day Moving Average 5.56
  • 200 Day Moving Average 3.3
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

DBV Technologies S.A (DBVT) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

DBV Technologies S.A (DBVT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2019-12-312020-03-04$N/A-$0.94-$1.6442.92%
2019-09-302019-09-30$N/A-$0.42-$0.4710.64%
2017-06-302017-07-28$8.69 million-$1.46-$1.8420.66%
2015-06-302015-07-27$1.97 million-$0.24-$0.5354.47%
2015-03-312015-04-29$1.56 million-$0.18-$0.5165.47%
2014-12-312015-03-26$2.12 million-$0.65-$0.40-62.5%

DBV Technologies S.A (DBVT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A N/A 27.82 million
Income Before Tax N/A N/A N/A N/A -41.85 million
Selling General Administrative N/A N/A N/A N/A 15.34 million
Gross Profit N/A N/A N/A N/A N/A
Ebit N/A N/A N/A N/A -39.63 million
Operating Income N/A N/A N/A N/A -40.87 million
Income Tax Expense -6835 -6761 1500 1500 528086.11
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A N/A -2.46 million
Net Income From Continuing Operations N/A N/A N/A N/A -42.32 million
Net Income Applicable to Common Shares -26.75 million -28.87 million -43.27 million -43.27 million -47.45 million
Cash Flow:
Date Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019
Investments N/A N/A -1.42 million -1.54 million 21048.84
Change to Liabilities 767000 767000 4.52 million -5.36 million -3.35 million
Total Cash Flow from Investing Activities -657500 -657500 -1.59 million -1.68 million -1.18 million
Net Borrowings -802500 -802500 -1.03 million -1.01 million -1.3 million
Total Cash Flow from Financial Activities N/A N/A 120.37 million -1.28 million 83.81 million
Change to Operating Activities -5.84 million -5.84 million 11.83 million 2.09 million -1.2 million
Change in Cash N/A N/A 98.69 million -33.92 million -20.4 million
Total Cash from Operating Activities -39.72 million -39.72 million -22.71 million -33.89 million -43.54 million
Depreciation N/A N/A 1.67 million 1.59 million 3.21 million
Other Cash Flow from Investing Activities N/A N/A -91656.52 N/A 31119.68
Change to Inventory N/A N/A 210000 -165000 -678824.97
Change to Account Receivables N/A N/A 30000 N/A 78933.15
Other Cash Flow from Financing Activities -242000 -242000 -16.97 million -358583.11 -309220.18
Change to Net Income 1.49 million 1.49 million 5.8 million 2.11 million 4.96 million
Capital Expenditures N/A N/A 1.37 million 1.51 million 2.79 million
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A N/A N/A 69.91 million
Total Stockholder Equity N/A N/A N/A N/A 171.56 million
Other Current Liabilities N/A N/A N/A N/A 18.1 million
Total Assets N/A N/A N/A N/A 241.48 million
Common Stock 205.27 million 205.27 million 5.49 million 5.49 million 5.27 million
Other Current Assets N/A N/A N/A N/A 20.03 million
Retained Earnings N/A N/A -86.54 million -86.54 million -153.59 million
Other Liabilities 66.75 million 66.75 million 1.2 million 1.2 million 1.73 million
Other Assets 75.67 million 75.67 million 21.1 million 21.1 million 13.65 million
Cash N/A N/A N/A N/A 172.03 million
Total Current Liabilities N/A N/A N/A N/A 48.07 million
Other Stockholder Equity N/A N/A -556.02 million -556.02 million -454.1 million
Property, Plant & Equipment N/A N/A 40.57 million 40.57 million 48.05 million
Total Current Assets 196.35 million 196.35 million N/A N/A 182.09 million
Long Term Investments N/A N/A N/A N/A 1.05 million
Net Tangible Assets 205.27 million 205.27 million 224.21 million 224.21 million 192.31 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A 721000
Inventory N/A N/A N/A N/A 2.04 million
Accounts Payable N/A N/A N/A N/A 21.37 million

DBV Technologies S.A (DBVT) Chart:

DBV Technologies S.A (DBVT) News:

Below you will find a list of latest news for DBV Technologies S.A (DBVT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

DBV Technologies S.A (DBVT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50.05CALL0 370FALSE00
2024-05-1750CALL0 00FALSE00
2024-05-177.50CALL0 00FALSE00
2024-05-172.50PUT0 01001.4TRUE00
2024-05-1750PUT0 01115.84TRUE00
2024-05-177.50PUT0 01181.39TRUE00
2024-08-162.50.05CALL0 19169.16FALSE00
2024-08-1650CALL0 00FALSE00
2024-08-162.50PUT0 00TRUE00
2024-08-1650PUT0 00TRUE00
2024-11-152.50.1CALL0 1182.49FALSE00
2024-11-1550CALL0 00FALSE00
2024-11-152.50PUT0 0653TRUE00
2024-11-1550PUT0 00TRUE00

Latest DBVT Trades:

Date Shares Price
Jun 13, 2022 7:57 PM EST1000$2.31
Jun 13, 2022 7:57 PM EST100$2.3
Jun 13, 2022 7:57 PM EST100$2.31
Jun 13, 2022 7:57 PM EST200$2.31
Jun 13, 2022 7:58 PM EST100$2.31

DBV Technologies S.A (DBVT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520180920/0001193125-20-180920-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613780/000089542120000079/0000895421-20-000079-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613780/000110259820000012/0001102598-20-000012-index.htm
2019-10-15SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1613780/000110465919054128/0001104659-19-054128-index.htm
2019-10-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1613780/000114420419048132/0001144204-19-048132-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613780/000117266120000879/0001172661-20-000879-index.htm
2019-10-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312519262728/0001193125-19-262728-index.htm
2019-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1613780/000119312519264551/0001193125-19-264551-index.htm
2019-10-09FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1613780/000119312519264577/0001193125-19-264577-index.htm
2019-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1613780/000119312519265115/0001193125-19-265115-index.htm
2019-10-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312519265129/0001193125-19-265129-index.htm
2019-10-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613780/000119312519266778/0001193125-19-266778-index.htm
2019-10-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312519267732/0001193125-19-267732-index.htm
2019-10-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312519273629/0001193125-19-273629-index.htm
2019-11-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312519284775/0001193125-19-284775-index.htm
2020-01-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520000728/0001193125-20-000728-index.htm
2020-01-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520004087/0001193125-20-004087-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520006362/0001193125-20-006362-index.htm
2020-01-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520018377/0001193125-20-018377-index.htm
2020-01-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1613780/000119312520018469/0001193125-20-018469-index.htm
2020-01-29FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1613780/000119312520018497/0001193125-20-018497-index.htm
2020-01-29F-3MEFRegistration statement to add securities to prior Form F-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1613780/000119312520018829/0001193125-20-018829-index.htm
2020-01-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1613780/000119312520019593/0001193125-20-019593-index.htm
2020-01-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520019634/0001193125-20-019634-index.htm
2020-02-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520024346/0001193125-20-024346-index.htm
2020-02-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520026901/0001193125-20-026901-index.htm
2020-02-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520029885/0001193125-20-029885-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613780/000119312520038321/0001193125-20-038321-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613780/000119312520038333/0001193125-20-038333-index.htm
2020-02-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520044804/0001193125-20-044804-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520046839/0001193125-20-046839-index.htm
2020-03-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520061968/0001193125-20-061968-index.htm
2020-03-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520075122/0001193125-20-075122-index.htm
2020-03-2020-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613780/000119312520080633/0001193125-20-080633-index.htm
2020-03-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520080766/0001193125-20-080766-index.htm
2020-03-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520091010/0001193125-20-091010-index.htm
2020-04-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520105378/0001193125-20-105378-index.htm
2020-04-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520112342/0001193125-20-112342-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520128798/0001193125-20-128798-index.htm
2020-04-30F-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1613780/000119312520128894/0001193125-20-128894-index.htm
2020-06-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520163492/0001193125-20-163492-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520180920/0001193125-20-180920-index.htm
2020-07-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520191870/0001193125-20-191870-index.htm
2020-07-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520206381/0001193125-20-206381-index.htm
2020-08-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520209288/0001193125-20-209288-index.htm
2020-09-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520242192/0001193125-20-242192-index.htm
2020-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520282574/0001193125-20-282574-index.htm
2020-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1613780/000119312520283937/0001193125-20-283937-index.htm
2019-10-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613780/000119380519001334/0001193805-19-001334-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613780/000119380520000186/0001193805-20-000186-index.htm
2019-10-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1613780/999999999519002219/9999999995-19-002219-index.htm